JAMP-Pregabalin recall in Canada: May contain incorrect dosage
In plain language
This recall involves one lot of JAMP-Pregabalin 50 mg capsules sold in Canada. It's being recalled because some bottles labelled as 50 mg may contain 150 mg capsules, which could lead to overdose. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check your medication bottle to ensure it only contains 50 mg capsules.
- Return the product to your pharmacy if it contains 150 mg capsules or if you are unsure.
- Seek immediate medical attention if you experience overdose symptoms.
- Do not stop taking pregabalin without speaking to your doctor.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
JAMP-Pregabalin 50 mg capsules
Lot: 2305012747
Date codes: 2026-08
Why this matters
Overdose risk from incorrect dosage
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the date code
Date codes are usually printed near the best-before date or on the packaging seam.
Affected date codes: 2026-08
- 3
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 2305012747
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Overdose risk from incorrect dosage
What should consumers do?
Stop using the product immediately. Check your medication bottle to ensure it only contains 50 mg capsules. Return the product to your pharmacy if it contains 150 mg capsules or if you are unsure. Seek immediate medical attention if you experience overdose symptoms. Do not stop taking pregabalin without speaking to your doctor.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Overdose risk from incorrect dosage
When was this product recalled?
This product was recalled on May 3, 2025.
Is the JAMP-Pregabalin brand affected by this recall?
Yes, JAMP-Pregabalin products are affected by this recall. This recall involves one lot of JAMP-Pregabalin 50 mg capsules sold in Canada. It's being recalled because some bottles labelled as 50 mg may contain 150 mg capsules, which could lead to overdose. Stop using the product and follow the return steps in the official notice.